Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Emisphere Technologies, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Emisphere Technologies, Inc. market cap is $475.25M.
What is the 52-week high for Emisphere Technologies, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Emisphere Technologies, Inc. 52 week high is $9.16 as of September 27, 2025.
What is the 52-week low for Emisphere Technologies, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Emisphere Technologies, Inc. 52 week low is $4.06 as of September 27, 2025.
What was Emisphere Technologies, Inc. stock price yesterday?
Emisphere Technologies, Inc. stock price yesterday was $7.81.
What is the 50-day moving average of Emisphere Technologies, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Emisphere Technologies, Inc. 50-day moving average is $7.64.